Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Scott C Bell

Showing results (181-190 of 203) with videos related to

Pageof 21
Sort By:
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
International Journal of Systematic and Evolutionary Microbiology|April 16, 2015
Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sourcesBirgit De Smet, Mark Mayo, Charlotte Peeters, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2020
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisRebecca Cosgriff, Susannah Ahern, Scott C Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2026
Multiple defects in macrophage antibacterial responses support intracellular survival of <i><i>Mycobacterium</i> abscessus</i> in cystic fibrosisAbdullah A Tarique, Stefan Emming, Dean Kelk, et al.
BMC Infectious Diseases|September 18, 2021
Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocolAmanda Brass, Andrew P Shoubridge, Maria Crotty, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2025
Infection by Clonally Related <i>Mycobacterium abscessus</i> Isolates: The Role of Drinking WaterRachel M Thomson, Nicole Wheeler, Rebecca E Stockwell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
BMC Pulmonary Medicine|October 11, 2015
An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosisJames B Geake, David W Reid, Bart J Currie, et al.
The European Respiratory Journal|October 11, 2015
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosisJ Stuart Elborn, Scott C Bell, Susan L Madge, et al.
Pageof 21

Showing results (181-190 of 203) with videos related to

Sort By:
Pageof 21
The Lancet. Respiratory Medicine|August 2, 2025
Maximising opportunity for therapeutic success: sequential participation in cystic fibrosis nucleic acid-based therapy trialsNicole Mayer-Hamblett, Natanya R Kerper, John P Clancy, et al.
International Journal of Systematic and Evolutionary Microbiology|April 16, 2015
Burkholderia stagnalis sp. nov. and Burkholderia territorii sp. nov., two novel Burkholderia cepacia complex species from environmental and human sourcesBirgit De Smet, Mark Mayo, Charlotte Peeters, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 8, 2020
A multinational report to characterise SARS-CoV-2 infection in people with cystic fibrosisRebecca Cosgriff, Susannah Ahern, Scott C Bell, et al.
Proceedings of the National Academy of Sciences of the United States of America|May 27, 2026
Multiple defects in macrophage antibacterial responses support intracellular survival of <i><i>Mycobacterium</i> abscessus</i> in cystic fibrosisAbdullah A Tarique, Stefan Emming, Dean Kelk, et al.
BMC Infectious Diseases|September 18, 2021
Prevention of SARS-CoV-2 (COVID-19) transmission in residential aged care using ultraviolet light (PETRA): a two-arm crossover randomised controlled trial protocolAmanda Brass, Andrew P Shoubridge, Maria Crotty, et al.
American Journal of Respiratory and Critical Care Medicine|March 12, 2025
Infection by Clonally Related <i>Mycobacterium abscessus</i> Isolates: The Role of Drinking WaterRachel M Thomson, Nicole Wheeler, Rebecca E Stockwell, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|May 7, 2019
CFTR activity is enhanced by the novel corrector GLPG2222, given with and without ivacaftor in two randomized trialsScott C Bell, Peter J Barry, Kris De Boeck, et al.
The New England Journal of Medicine|November 4, 2011
A CFTR potentiator in patients with cystic fibrosis and the G551D mutationBonnie W Ramsey, Jane Davies, N Gerard McElvaney, et al.
BMC Pulmonary Medicine|October 11, 2015
An international, multicentre evaluation and description of Burkholderia pseudomallei infection in cystic fibrosisJames B Geake, David W Reid, Bart J Currie, et al.
The European Respiratory Journal|October 11, 2015
Report of the European Respiratory Society/European Cystic Fibrosis Society task force on the care of adults with cystic fibrosisJ Stuart Elborn, Scott C Bell, Susan L Madge, et al.
Pageof 21